173 related articles for article (PubMed ID: 26922887)
21. European Working Group on Clinical Cell Analysis (EWGCCA): 6 years on.
Papa S;
J Biol Regul Homeost Agents; 2002; 16(4):253-6. PubMed ID: 12597640
[No Abstract] [Full Text] [Related]
22. Medical Devices; Hematology and Pathology Devices; Classification of the Flow Cytometric Test System for Hematopoietic Neoplasms. Final order.
Food and Drug Administration, HHS
Fed Regist; 2017 Dec; 82(247):61163-6. PubMed ID: 29319938
[TBL] [Abstract][Full Text] [Related]
23. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, Maryland, November 16-17, 1995.
Cytometry; 1997 Oct; 30(5):213-74. PubMed ID: 9383094
[No Abstract] [Full Text] [Related]
24. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
Lanza F
Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
[No Abstract] [Full Text] [Related]
25. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis.
Gratama JW; Kraan J; Adriaansen H; Hooibrink B; Levering W; Reinders P; Van den Beemd MW; Van der Holt B; Bolhuis RL
Cytometry; 1997 Feb; 30(1):10-22. PubMed ID: 9056737
[TBL] [Abstract][Full Text] [Related]
26. 2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.
Stetler-Stevenson M; Davis B; Wood B; Braylan R
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S3. PubMed ID: 17630651
[No Abstract] [Full Text] [Related]
27. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation.
Borowitz MJ; Bray R; Gascoyne R; Melnick S; Parker JW; Picker L; Stetler-Stevenson M
Cytometry; 1997 Oct; 30(5):236-44. PubMed ID: 9383097
[No Abstract] [Full Text] [Related]
28. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.
Stelzer GT; Marti G; Hurley A; McCoy P; Lovett EJ; Schwartz A
Cytometry; 1997 Oct; 30(5):214-30. PubMed ID: 9383095
[No Abstract] [Full Text] [Related]
29. Flow cytometry: an overview.
Villas BH
Cell Vis; 1998; 5(1):56-61. PubMed ID: 9660728
[TBL] [Abstract][Full Text] [Related]
30. When laboratories go with flow analysis.
Check W
CAP Today; 1998 Nov; 12(11):1, 20, 26 passim. PubMed ID: 10339304
[No Abstract] [Full Text] [Related]
31. Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines?
Basso G; Lanza F; Orfao A; Benè M; Borowitz M; Campana D; Lacombe F; Ludwig WD; Porwitt-MacDonald A; Rothe G; Dworzac M;
J Biol Regul Homeost Agents; 2002; 16(4):257-8. PubMed ID: 12597641
[No Abstract] [Full Text] [Related]
32. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
Calvo KR; McCoy CS; Stetler-Stevenson M
Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids.
Cesana C; Klersy C; Scarpati B; Brando B; Volpato E; Bertani G; Faleri M; Nosari A; Cantoni S; Ferri U; Scampini L; Barba C; Lando G; Morra E; Cairoli R
Leuk Res; 2010 Aug; 34(8):1027-34. PubMed ID: 20206995
[TBL] [Abstract][Full Text] [Related]
34. An online decision support system for diagnosing hematopoietic malignancies by flow cytometry immunophenotyping.
Qian YW; Mital D; Lee S
AMIA Annu Symp Proc; 2007 Oct; ():1084. PubMed ID: 18694182
[TBL] [Abstract][Full Text] [Related]
35. Toward Standardization of Flow-Cytometric Immunophenotyping for the Diagnosis and Monitoring of Hematologic Malignancies.
Kim SY; Huh HJ
Ann Lab Med; 2024 May; 44(3):193-194. PubMed ID: 38145894
[No Abstract] [Full Text] [Related]
36. Diversity amongst various guidelines for immunophenotyping.
Gujral S; Subramanian PG; Dasgupta A
Cytometry A; 2009 Jul; 75(7):560-1. PubMed ID: 19504568
[No Abstract] [Full Text] [Related]
37. Clinical flow cytometry: a transition in utilization.
Goolsby CL; Paniagua M; Marszalek L
Cancer Treat Res; 2004; 121():239-57. PubMed ID: 15217213
[No Abstract] [Full Text] [Related]
38. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.
Béné MC; Nebe T; Bettelheim P; Buldini B; Bumbea H; Kern W; Lacombe F; Lemez P; Marinov I; Matutes E; Maynadié M; Oelschlagel U; Orfao A; Schabath R; Solenthaler M; Tschurtschenthaler G; Vladareanu AM; Zini G; Faure GC; Porwit A
Leukemia; 2011 Apr; 25(4):567-74. PubMed ID: 21252983
[TBL] [Abstract][Full Text] [Related]
39. A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry.
Nguyen AN; Milam JD; Johnson KA; Banez EI
Am J Clin Pathol; 2000 Jan; 113(1):95-106. PubMed ID: 10631862
[TBL] [Abstract][Full Text] [Related]
40. Issue Highlights - July 2019.
Cytometry B Clin Cytom; 2019 Jul; 96(4):253-255. PubMed ID: 31321907
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
